Abstract
Purpose: Here we report the results of a review of a prospectively maintained database of the use polyacrylate polyalcohol copolymer (PPC) injection to correct grades IV and V VUR.Materials and Methods: All children with grades IV and V primary VUR that presented with febrile urinary tract infection while on prophylaxis, in a 3-year period, were treated with a sub-ureteral injection of PPC. Institutional ethical approval was obtained. Exclusion criteria were incomplete bladder emptying documented on videourodynamic study, ureteral duplication, paraureteral diverticula, and poor ureteral emptying observed during fluoroscopy and previous open surgical or endoscopic treatment. Pre- and post-operative evaluation included urinalysis, renal and bladder ultrasonography, DMSA scan, and videourodynamic studies.Results: Thirty-three children [36 renal units (RU)] were included with a median age of 57 months (range 7–108). There were 18 boys and 15 girls. Thirty RU had grade IV and 6 grade V VUR. Median follow-up time was 32 months (range 7–58). Reflux was cured in 32/36 RU with the first injection, but another two patients were reimplanted because of dilatation. Complications included early urinary tract infection in seven children, transient lower urinary tract symptoms in five children. Progressive ureteral dilatation was noted in four children and was treated with insertion of a double J stent. Two of these children eventually required an ureteroneocystostomy.Conclusion: The use of PPC to treat grades IV and V vesicoureteral reflux in young children has an overall success rate of 83.3%. Persistent ureteral dilatation was present in 11% associated with high injection volume. Future studies will attempt to maintain a high success rate reducing the volume of injection and the incidence of dilatation.
Highlights
The treatment of grades IV and V primary vesicoureteral reflux (HGVUR) is dependent on the age of the child, symptoms, and status of the kidneys
Materials and Methods: All children with grades IV and V primary VUR that presented with febrile urinary tract infection while on prophylaxis, in a 3-year period, were treated with a sub-ureteral injection of polyacrylate polyalcohol copolymer (PPC)
Reflux was cured in 32/36 renal units (RU) with the first injection, but another two patients were reimplanted because of dilatation
Summary
The treatment of grades IV and V primary vesicoureteral reflux (HGVUR) is dependent on the age of the child, symptoms, and status of the kidneys. Given the high-resolution rate of reflux in children, medical treatment with antibiotic prophylaxis is preferred [1]. The resolution rate of HGVUR is low [1]. When surgical treatment is required because of nonresolution, breakthrough infections, or low expectation of spontaneous resolution, many urologists choose the endoscopic injection. There is a parental preference for endoscopic treatment. This carries an acceptable success rate with lower morbidity and cost, no scars, as an outpatient procedure [2, 3]. The initial experience with polyacrylate polyalcohol copolymer (PPC) in a multicenter study in all grades of VUR had an 83.6% success rate [3]. The possible benefit of PPC for treating HGVUR is the long term of the results since it is a non-absorbable substance
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
